Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Phenotypic multi-nucleoside re...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Phenotypic multi-nucleoside resistance linked to the Q151M mutation is enhanced under the selective pressure of acyclic nucleotide analogs but reduced by foscarnet
Bibliographic Details
Main Authors:
Van Laethem, K
,
Witvrouw, M
,
Pannecouque, C
,
Van Remoortel, B
,
Esnouf, R
,
Balzarini, J
,
Desmyter, J
,
De Clercq, E
,
Vandamme, A
Format:
Journal article
Published:
2000
Holdings
Description
Similar Items
Staff View
Description
Summary:
Similar Items
Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype.
by: Van Laethem, K, et al.
Published: (2001)
1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity.
by: Witvrouw, M, et al.
Published: (1998)
Coordination Chemistry of Nucleotides and Antivirally Active Acyclic Nucleoside Phosphonates, including Mechanistic Considerations
by: Astrid Sigel, et al.
Published: (2022-04-01)
Lack of susceptibility of bicyclic nucleoside analogs, highly potent inhibitors of varicella-zoster virus, to the catabolic action of thymidine phosphorylase and dihydropyrimidine dehydrogenase.
by: Balzarini, J, et al.
Published: (2002)
Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
by: Auwerx, J, et al.
Published: (2004)